Treatment-resistant depression (TRD) affects millions of Americans and carries significant personal, clinical, and economic consequences. In this episode of the Health Policy Podcast, host Bryan Hyde speaks with Dr. William Sauvé, Chief Medical Officer of Osmind, and Mark Desmarais, Principal at Health Management Associates, about new research examining the impact of TRD on patients and the healthcare system.

Drawing on a comprehensive analysis of Medicare claims data, Desmarais explains how patients with TRD generate approximately $8,000 more in annual healthcare costs than patients whose depression is effectively managed. The discussion explores the reasons behind these costs, including higher rates of physician visits and hospitalizations, as well as their impact on both individuals and caregivers.

Dr. Sauvé, a psychiatrist with extensive experience treating complex depression cases in both military and civilian settings, discusses TRD, the challenges patients face after multiple unsuccessful medication trials, and the importance of identifying effective treatments. The conversation also examines workforce shortages in mental health care, barriers posed by prior authorization requirements, and how delaying effective treatment can worsen patient outcomes and increase healthcare spending.

Drug policy analyst Layal Bou Harfouch discusses the unintended consequences of New Mexico's SB 42, which allows the state to mandate treatment or remove newborns based on substance exposure. She explores how centralized, one-size-fits-all mandates bypass clinical assessments and create dangerous disincentives for mothers seeking prenatal care.

Dr. Gail C. Christopher, Executive Director of the National Collaborative for Health Equity, discusses the "Momnibus" Act and the multi-decade effort to eliminate racial disparities in maternal health. She shares promising policy shifts, including the expansion of Medicaid coverage for doula services and the bipartisan momentum behind comprehensive birth equity.

Pete Sepp, President of the National Taxpayers Union, joins the show to discuss why healthcare costs remain high, unpredictable, and opaque. Sepp breaks down the perverse incentives across the industry—from site-neutrality issues and "pay and chase" government models to the bureaucratic overhead that consumes up to 30% of expenditures.

On the Health Policy Podcast, attorney and mental health reform advocate Ellen Lubensky discusses her concerns about the use of psychiatric medications and the lack of informed consent in mental health care. Drawing from personal experience, she argues that patients are often prescribed medications during brief appointments without a full understanding of potential risks, including dependency and withdrawal effects. Lubensky calls for greater transparency from physicians, longer consultation times, and systemic changes in funding that would prioritize therapy and patient education before medication. She also highlights barriers within insurance and disability systems that may discourage alternative treatments. Her core message to listeners is to advocate for themselves, ask questions, and seek providers who take the time to explain treatment options thoroughly.

In this episode of the Health Policy Podcast, clinical pharmacist and MAHA Report contributor Amy Sapola discusses the growing recognition of sleep deprivation among adolescents as a structural public health issue. She explains how early school start times conflict with teenage circadian rhythms, contributing to widespread sleep deficits that impact academic performance, mental health, immune function, and even traffic safety. Sapola outlines research showing that modest delays in school start times can significantly improve outcomes, while also addressing the downstream effects of poor sleep, including increased reliance on caffeine and energy drinks.

The conversation explores the balance between policy solutions and personal responsibility, highlighting practical steps families can take around screen use, nutrition, and activity. Sapola argues that sleep should be treated as a foundational pillar of health policy, with growing attention at the national level through initiatives like the MAHA Commission.

In a wide-ranging discussion on the Health Policy Podcast, Mike Smith, President Emeritus at The Brokerage Inc., outlines how the Affordable Care Act expanded coverage to millions of previously uninsured Americans but failed to deliver on long-term affordability. Smith explains that while subsidies helped drive enrollment and improve access to care, rising base premiums and the expiration of enhanced tax credits in late 2025 have led many consumers to drop coverage.

He describes a market now marked by instability, limited private-sector solutions, and growing reliance on government funding, warning that current trends could push the U.S. closer to a national healthcare system if sustainable reforms are not found

Ross Marchand, executive director of the Taxpayers Protection Alliance, discusses his organization's report Blocking Breakthroughs, which examines FDA drug rejection rates. He said that regulatory barriers, shifting standards, and excessive risk aversion are delaying patient access to potentially life-saving treatments, even as other developed countries approve the same drugs.